Select the Industry/ Sector šŸ‘‰    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,708.9
₹56,302 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹26,189.3
₹55,650 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,105.5
₹26,512 Cr
Pharmaceuticals & Drugs
₹968.6
₹19,039 Cr
Pharmaceuticals & Drugs
₹490.8
₹4,512 Cr
Pharmaceuticals & Drugs
₹460.1
₹4,170 Cr
Pharmaceuticals & Drugs
₹359.2
₹4,017 Cr
Pharmaceuticals & Drugs
₹91.7
₹2,355 Cr
Pharmaceuticals & Drugs
₹1,147.7
₹655 Cr
Pharmaceuticals & Drugs
₹46.4
₹130 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,708.9
₹12,634 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹968.6
₹6,118 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,105.5
₹4,036 Cr
Pharmaceuticals & Drugs
₹490.8
₹2,651 Cr
Pharmaceuticals & Drugs
₹460.1
₹1,832 Cr
Pharmaceuticals & Drugs
₹359.2
₹605 Cr
Pharmaceuticals & Drugs
₹91.7
₹146 Cr
Pharmaceuticals & Drugs
₹26,189.3
₹5,753 Cr
Pharmaceuticals & Drugs
₹1,147.7
₹355 Cr
Pharmaceuticals & Drugs
₹46.4
₹343 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,708.9
₹1,575 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,105.5
₹736 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹968.6
₹599 Cr
Pharmaceuticals & Drugs
₹460.1
₹195 Cr
Pharmaceuticals & Drugs
₹490.8
₹180 Cr
Pharmaceuticals & Drugs
₹359.2
₹139 Cr
Pharmaceuticals & Drugs
₹91.7
₹76 Cr
Pharmaceuticals & Drugs
₹26,189.3
₹1,146 Cr
Pharmaceuticals & Drugs
₹1,147.7
₹66 Cr
Pharmaceuticals & Drugs
₹46.4
₹4 Cr

You may also like the below Video Courses